Diosmin is a naturally occurring flavone glycoside used in the treatment of venous diseases. In this review, we present the clinical aspects of the use of diosmin preparations in venous stasis, hemorrheologic disorders and vein wall remodeling. Because of its multiple applications in biology and its many therapeutic activities, research on isolation and identification of diosmin is of high relevance. The aim of this review is to present an overview of techniques of isolation and separation of diosmin in plant material, pharmaceutical formulations such as Daflon ® , Diosed ® and Dioven ® tablets, and biological fluids.
Diosmin, the 7-rhamnoglucoside of 5,7,3-trihydroxy-4methoxyflavone; IUPAC name: {5-hydroxy-2-(3-hydroxy-4methoxyphenyl)-7-[(2S,3R,4S,5S,6R) -3,4,5-trihydroxy-6-[[(2R,3R, 4R ,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2yl]oxychromen-4-one} and its flavanone analog hesperidin, are common flavonoids in the Rutaceae family [1a] . Diosmin differs from hesperidin by the presence of a double bond between two carbon atoms in the C-ring of the diosmin molecule. Diosmin can be manufactured by extracting hesperidin from citrus rinds, followed by conversion of hesperidin to diosmin [2a] .
Diosmin was first isolated in 1925 from Scrophularia nodosa L., and first introduced as a therapeutic agent in 1969 [3] . Nowadays it is widely used for its phlebotonic and vascular-protecting activity in treatment of chronic venous insufficiency, lymphedema and varicose veins [1a,3] . The therapeutic action of diosmin is attributed to the inhibitory effect on capture and metabolism of noradrenalin by the venous walls. This results in an increase in the vascular tonus with favorable consequences, reduction of elasticity and permeability [4] . As a flavonoid, diosmin also exhibits antiinflammatory, free-radical scavenging, and antimutagenic properties [1a,3] . Diosmin possesses an antihypertensive effect, which is evidenced by lowered blood pressure, lipid peroxides, improved nitric oxide availability and antioxidant status. Scavenging of superoxide anions by diosmin is attributed to its antioxidant effect and leads to the increase in nitric oxide availability which infers relaxation of the vessel wall and controls blood pressure. The antihypertensive effect of diosmin was evaluated in deoxycorticosterone acetate (DOCA)-salt induced hypertension in male Wistar rats and the maximum efficacy was reached with a medium dose of 50 mg/kg body weight [5] .
Diosmin is very popular in the treatment of chronic venous insufficiency (CVI), which affects an ever increasing number of people. CVI is characterized by pain, leg heaviness, a sensation of swelling, and cramps, and is correlated with varicose veins. The complications in CVI are usually associated with inflammatory and thromboembolic processes. The progress of the disease can be slowed down, especially if adequate treatment is used. After the administration of 600 mg of diosmin for 60 days, parameters of pain and edema in four groups of patients with different severity of clinical and pathomorphological findings were significantly improved [2a,3] . It is worthy of notice that diosmin in a dose of 600 mg is usually prescribed in CVI, but a dose 1000 mg per day would be more adequate [2b] .
Several large clinical trials have demonstrated diosmin to be effective in the treatment of acute and chronic symptoms of hemorrhoids [3] . Diosmin significantly reduced cell death caused by lipopolysaccharide in a concentration-dependent manner. Diosmin also dose-dependently suppressed LPS-induced tumor necrosis factor-alpha TNF-α expression, and the apoptotic mechanisms in rat pheochromocytoma PC12 cells via the inhibition of a caspase-dependent apoptotic pathway [6] . Oral treatment with diosmin (100 mg/kg/day) for a period of 45 days showed significant ameliorative effects on all the biochemical parameters in oxidative stress in streptozotocin-nicotinamide (STZ-NA)-induced diabetic rats. Oxidative stress has been suggested as a contributory factor in development and complication of diabetes [7] . Glinski et al. proposed diosmin as being effective in treatment of venous ulceration and delayed healing [8] .
After oral administration, diosmin is rapidly hydrolyzed by enzymes of the intestinal microflora into its flavone aglycone, diosmetin, which is subsequently absorbed into the systemic circulation. After 26-43 h diosmetin is degraded to phenolic acids or their glycine-conjugated derivatives and eliminated through the urine. Diosmin and diosmetin that are not absorbed are eliminated in the feces [2c, 3, 9] . Diosmin has a wide range of biological activities,  including  anti-inflammatory,  blood  lipid  lowering,  antihyperglycemic, antioxidant and free radical scavenging effects  [1e ,6,7] . Recent studies have shown the use of diosmin for the treatment of venous leg ulcer and, as a chemopreventive agent, in urinary -bladder and colon carcinogenesis [1a,e,6] . It is also a potential agent for the treatment of neurodegenerative diseases [6] . Because diosmin has many applications in biology and therapeutics, methods for isolation and identification of this compound are of high practical relevance. In this part of our work, an overview of the possible methods of isolation of diosmin is given.
Determination in plant extracts and pharmaceutical formulations:
Diosmin typically appears as a greyish-yellow or light yellow hygroscopic powder [10] . The choice of an optimal extraction procedure for obtaining pure diosmin from biological material is very important and depends on the goals of the conducted research. Different methods of isolation may be applied, and the utilization of various strategies is dependent on the origin of the biological material from which diosmin is to be extracted.
Diosmin, unlike most flavonoid compounds, is very poorly soluble both in polar and nonpolar protic solvents, but freely soluble in some aprotic solvents, for example, dimethyl sulfoxide. This procedure makes it possible to separate the target compound rather easily from accompanying flavonoids. According to the method proposed by Ivashev et al. [4] plant material (Hyssopus officinalis L., Lamiaceae), after defatting with chloroform, was treated with aqueous ethanol or water (and subsequently with 96% ethanol), and then diosmin was extracted from the plant material with dimethyl sulfoxide DMSO. The extracts obtained were combined and poured into a tenfold amount of water and a crystalline precipitate of diosmin was separated within 48 h. Purification by recrystallization from DMSO-water and DMSO-methanol mixtures and washing with ethanol was suggested to further purify diosmin from accompanying compounds [4] .
Diosmin, hesperidin and other flavonoids from citrus peels were extracted and the effect of water content in the citrus peel (0% and 75%), the extraction time (30 and 90 min) and the citrus peel/water ratio were evaluated. The citrus peels were obtained from three species: tahiti lime {Citrus latifolia (Tanaka ex Yu.Tanaka) Tanaka, sweet orange [C. sinensis (L.) Osbeck], and oneco tangerine (C. reticulata Blanco)}. The highest yield was obtained from dry material with 30 min of extraction. In contrast, with 30 min and wet material the lowest yield was obtained. With wet material it was demonstrated that the yield increased with extraction time. The yields from dry material were higher than those from wet material and the extraction time had no influence on the phenolic content. According to these results the optimal ultrasound-assisted extraction conditions were set as follow: frequency 60 kHz, extraction time 30 min, temperature 40˚C, citrus peel/water ratio (g/mL) 1/10, Ca(OH) 2 as basifying agent, and water as solvent [1b] .
For the isolation of diosmin from Buchu {(Barosma betulina (Thunb.) Bartl. and H.L.Wendl., Rutaceae} leaves, El-Shafae et al. [1a] proposed refluxing with methanol containing 10% dimethylsulfoxide (4 x 15 min). These authors determined diosmin from tablets, too. In this case, weighed and powdered tablets were refluxed with the same solvent (3 x 5 min). Incorporation of 10% dimethylsulfoxide in methanol provided the most efficient solvent for complete extraction of diosmin. A different method of extraction from pharmaceutical formulations was suggested by Moldovan et al. [11a] . Tablets containing diosmin were ground into powder and extracted with 0.5 M NaOH. Then samples were filtered and quantitatively transferred into calibrated flasks with doublydistilled water. Diosmin, together with other flavonoids, was extracted from citrus peels using optimal ultrasound-assisted extraction with water. After acidification to pH 7, precipitates were obtained by centrifugation and were dissolved in dimethyl sulfoxide: methanol (2:1, v/v) and filtrated through 0.45 µm nylon membrane and used for HPLC analysis [1c].
Commercial citrus fruit juices and freshly prepared hand-squeezed citrus fruit juices were sonicated at room temperature for 15 min and filtered before use. Five Daflon tablets (a mixture of micronized flavonoid glycosides consisting of 450 mg of diosmin and flavonoid extract equivalent to 50 mg of hesperidin) were powdered, and sonicated at 30˚C with 90 mL of methanol/DMSO (1:1) for 30 min [1e].
A sensitive, accurate and precise bioanalytical method involving a simple liquid-liquid extraction of diosmin from plasma samples was developed. Plasma samples were incubated with βglucuronidase/sulfatase in order to release diosmetin from its glucuronic acids conjugate. The analytes were isolated by liquidliquid extraction with tert-butyl methyl ether at pH 2. Tert-butyl methyl ether in acidic media proved to be the best in terms of high extraction recovery, negligible matrix effects, and absence of endogenous interference at the retention times in the chromatogram [1f].
Polyamide as a sorbent has been used for cleaning samples before analysis of diosmin in natural samples. Lime (Citrus latifolia) juice containing diosmin and hesperidin was centrifuged for 10 min, mixed with 25 mL of double distilled deionized water, adjusted to pH 3 with concentrated HCl and filtered to remove solid particles. The SPE polyamide cartridge was sequentially conditioned with 5 mL of n-hexane, 5 mL of methanol and 10 mL of double distilled deionized water without allowing the cartridge to dry. The authors had also studied the effects on extraction efficiency of some parameters including percentage of methanol in washing solution, pH of washing solution, type and volume of elution solvent and flow rate of sample solution through the cartridge. For optimizing the washing solution, different percentages of methanol in water at different pHs ranging from 2.5 to 7.5 were examined. To obtain a suitable solvent for elution of analytes from the cartridge, different solvents such as methanol, acetonitrile, ethylacetate, diethylether, nhexane and acetone were examined [1c].
Separation and detection:
There are a number of methods for diosmin determination in pharmaceutical formulations, plant material and biological fluids. These methods include voltammetry, thin-layer chromatography, high performance liquid chromatography (HPLC), Fourier transform infrared spectroscopy and spectrodensitometry [1a,e,g,11a,b,12a] . Comparison of many techniques used for determination of diosmin in different samples is shown in Table 1 .
Spectroscopic and spectrophotometric methods:
A Fourier transform infrared (FT-IR) spectroscopic method was developed for the rapid, direct measurement of diosmin in different pharmaceutical drugs. Beer's law and/or chemometric methods (partial least squares PCR+, principal component Regression PLS1 or PLS2) were used in order to minimize the effects of sample pretreatment steps and provide direct FT-IR measurement. The method proposed is simple, precise and not time-consuming compared with the chromatographic methods that exist in the literature. Quantification was achieved in about 10-15 min, including sample preparation and spectral acquisition [11b].
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Natural Product Communications Vol. 8 (4) 2013 547 A rapid and sensitive spectrophotometric method for the determination of diosmin has been developed. The method is based on the reaction of the target compound with 4-aminoantipyrine (AAP) in the presence of hexacyanoferrate (III) (HCF) in an alkaline medium and subsequent formation of a purple colored product having a maximum absorption (λ max ) at 524.5 nm. The reaction with AAP in the presence of an oxidant such as hexacyanoferrate (III) in alkaline solution is one of the most widely used reactions for the determination of phenols. The conditions affecting the reaction (reagents concentration, pH, order of addition of reagents, stability in time) were optimized. Under the optimum conditions, Beer's law was proven to be valid in the range of 0.3 -35 μg mL -1 diosmin with a correlation coefficient of 0.9993, LOD (calculated as three times the standard deviation of the blank) = 0.1 µg mL -1 and LOQ = 0.3 µg mL -1 . The proposed method was successfully applied to the analysis of drug tablet formulations. This method is inexpensive, fairly rapid and sensitive [11c] . A simple, rapid, economical and sensitive method for the spectrophotometric determination of diosmin has been developed using sodium nitroprusside as a chromogenic reagent. Diosmin, as a phenolic compound, reacts with sodium nitroprusside and hydroxylamine hydrochloride in a basic medium to give a green-colored product measured at an analytical wavelength of 763 nm. The proposed method was applied to determine diosmin in a commercial dosage form. The limits of detection (LOD) and quantification (LOQ) were 0.05 and 0.2 µg mL -1 , respectively. The method can be successfully applied as an alternative to the AAP method for the routine analysis of diosmin in pharmaceutical formulations [11a] .
Electroanalytical methods: An investigation of the oxidative behavior of diosmin at a glassy carbon electrode (GCE) using cyclic voltammetry (CV) and differential pulse voltammetric (DPV) techniques, and also an optimization of the experimental conditions for the determination of this compound in pharmaceutical dosage forms was performed. Tablets containing 150 mg diosmin were dissolved in NaOH (0.02 M). A series of Britton-Robinson (BR) universal buffer solutions of various pH values ranging from pH 2.0 -10.0 were prepared and used as supporting electrolytes. The BR buffer solutions were prepared by mixing an acid mixture containing acetic (0.04 M), orthophosphoric (0.04 M), and boric acids (0.04 M), and adjusting the pH with an appropriate volume of sodium hydroxide (0.2 M) solution to the required pH. The oxidation process of the drug was found to be quasi-reversible with an adsorption controlled step. The adsorption stripping response was evaluated with respect to various experimental conditions, such as the pH of the supporting electrolyte, the accumulation potential and the accumulation time. The proposed voltametric methods at the GCE provided the advantages of simplicity, precision and accuracy for the analysis of diosmin compared with other reported methods (spectrophotometric and HPLC). The methods are also free from any interference of commonly used excipients and additives in the formulations of the drug [12a] . Hanuštiak et al. [12b] suggested an electrochemical technique for the determination of diosmin and other flavonoids by square wave voltammetry using a carbon paste electrode as a working electrode. The measurements were performed using the following parameters: initial potential 0.1 V, end potential 1.2 V, pulse amplitude 49.85 mV, step potential 1.95 mV, frequency 180 Hz. As a supporting electrolyte phosphate buffer (0.1 M NaH 2 PO 4 + 0.1 M Na 2 HPO 4 , pH 7) was used. The carbon paste was made of graphite powder and mineral oil (70:30, w/w). The limit of detection of diosmin was 2.66 µM. The proposed method is a simple, low cost and sensitive technique for the determination of diosmin in biological material [12b] . Adam et al. [12c] suggested and optimized an electrochemical technique for the determination of diosmin and other selected flavonoids in body liquids. The most suitable conditions for determination of the flavonoids were the following: frequency 180 Hz, step potential 1.95 mV/s and phosphate buffer of pH 7 as supporting electrolyte. The limit of detection and limit of quantification of diosmin were 2.66 and 8.88 nM, respectively. The suggested method could be used for analysis of body liquids such as urine. Chromatographic methods: For the fast determination of diosmin in complex pharmaceutical preparations a thin-layer chromatographic method with densitometric UV detection was developed. Chromatographic separation on silica gel was performed with chloroform-methanol-water (23 + 12 + 2, v/v), as mobile phase and the developed spots were analyzed by densitometry at λ = 344 nm. Under the experimental conditions established, repeatable and accurate results were obtained. The method is characterized by high sensitivity; the limit of detection was 20 ng [1g]. A HPTLCdensitometric method was used for the simultaneous quantitative determination of diosmin in citrus fruit extracts and in pharmaceutical preparations. The determination was carried out at 330 nm in the reflection mode. A mobile phase of ethyl acetatemethanol -water -acetic acid (25:2:2:1, v/v/v/v) was used [1h].
Reverse-phase high-performance liquid chromatography combined with different detectors is the commonly used analytical method for the separation and identification of flavonoids. A method has been developed for the simultaneous determination of diosmin, hesperidin and naringin in different citrus fruit juices and pharmaceutical preparations. Compounds were separated using tetrahydrofuran/water/acetic acid (21:77:2, v/v/v) as the mobile phase at 34˚C, using a C 8 reversed-phase column and with a UV-VIS detector. The method has been successfully applied to the determination of all three flavonoid glycosides in several samples of different citrus fruit juices and for the determination of diosmin and hesperidin in pharmaceutical preparations. The technique is simple, specific, precise and accurate [1e]. An HPLC method was established for the simultaneous determination of diosmin, hesperidin and eriocitrin in Iranian lime juice. The filtrate was passed through a polyamide cartridge, washed with 8 mL water/methanol (90:10 v/v, adjusted at pH = 3 with concentrated HCl) to remove interferences and eluted with 4 mL HPLC grade methanol. The eluate was dried and dissolved in 1 mL of acetonitrile, filtered and injected into the HPLC system. HPLC separation of hesperidin and diosmin was performed using a mobile phase consisting of water/acetonitrile/acetic acid (78:19:3, v/v) with a flow rate of 0.8 mL/min at room temperature. The analytes were monitored at 280 nm. Limit of detection (LOD; 0.0283 µg/mL), limit of quantification (LOQ; 0.0857 µg/mL), recovery (93.3±4.1-Bogucka -Kocka et al.
95.4±3.9), repeatability of retention times (4.7%) and peak areas (3.6%) were determined after eight injections. The results showed good sensitivity, linearity and repeatability, and the method was found to be suitable for quality control and routine analysis of diosmin in natural samples [1c] .
High pressure liquid chromatography was used for determination of diosmin and other flavonoids in extracts from citrus peels. The HPLC analysis was performed using a C8 column (250 x 4,6; 5 µm) . A photodiode array detector was set to 290 and 360 nm monitoring wavelength. The mobile phase consisted of water with 0.1% formic acid and acetonitrile and was used in an isocratic program with 25% acetonitrile. The flow-rate was 0.75 mL/min. The ESI-MS were acquired in positive mode. In order to obtain a Collision Induced Dissociation (CID), a fragmentor voltage of 70-190 V was used [1b] . The structural information about carbohydrate sequence, aglycone moiety and the diglycosidic linkage was achieved. A simple, selective and sensitive reversed -phase HPLC method was developed for the determination of diosmin and hesperidin in Buchu leaves and tablets containing these flavonoids. The mobile phase, consisting of methanol -water (60:40, v/v) in a simple isocratic mode, gave optimum chromatographic separation of diosmin and hesperidin [1a] .
A sensitive, accurate and precise bioanalytical method involving a simple liquid-liquid extraction of plasma samples and a LC-MS/MS determination of diosmin and diosmetin was developed and validated to meet the requirements for pharmacokinetic investigations. The analytes were separated on a C18 reversedphase column using a mixture of methanol/1% aqueous formic acid (58:42, v/v) at a flow rate of 0.5 mL/min. APCI in the positive ion mode and multiple reactions monitoring (MRM) was employed. Although diosmin and diosmetin have similar structures their physicochemical properties represented a problem for their extraction from biological samples. Previous HPLC methods involved the use of sodium hydroxide solution for diosmin extraction, but strong alkalis may convert flavanones to the corresponding chalcone derivatives, causing misleading results. The limit of detection of diosmin in plasma was 0.13 ng/mL (S/N=3) and the estimated LOQ was calculated as low as 0.34 ng/mL (S/N=10) [1f]. The proposed method was quicker and gave better LOD and LOQ values than the method described by Kanaze et al. [1d] . In this method, optimum chromatographic separation of diosmin, hesperidin, naringenin and the internal standard (rhoifolin) were achieved using a C8 reversed-phase column and tetrahydrofuran/water/acetic acid (21:77:2, v/v/v) as the mobile phase.
Also a micro HPLC-ESI/MS method was established as a rapid and easy technique. The micro HPLC was coupled on-line with an MS detector equipped with an ESI source operating in the negative mode. The use of microcolumn HPLC greatly enhanced detection performance. The method can be very useful in the analysis of the natural complex of citrus flavonoids, for the identification of components for which corresponding standards are not available, and for the quantitation of components present in low amounts due to the lower limit of detection of this method [1i].
Additionally, a GC/MS method for the simultaneous determination of diosmetin and hesperetin in human plasma and urine has been developed and validated. Samples were separated on an HP-5MS fused-silica capillary column (30 m × 0.25 mm, film thickness 0.25 μm). The injector and interface temperatures were set at 280°C. The column temperature was initially held at 80˚C for 1 min, and then raised to 310˚C at a rate of 20˚C per min and held for 10 min. The injection volume was 1 μL and the total run time was 24.5 min. The dried extracts were derivatized by the addition of pyridine and the derivatization reagent BSTFA + TMCS 1% and heated at 80˚C for 3 h. Finally, the trimethylsilyl (TMS) derivative mixture was injected into the gas chromatograph-mass spectrometer (GC-MS) system for analysis [1j] .
Venous stasis, hemorrheologic disorders and vein wall remodeling:
The complex activity of diosmin was shown to impact on all the above elements of venous pathology and to exert a synergic effect on vein walls and lymphatic vessels. Managing venous stasis therefore requires that venous return be stimulated first [2a,8,13a] . Venous stasis increases the risk of thromboembolic complications -some hemodynamic factors play a role in the development of venous thrombi. It was demonstrated that ADP released by pathological, deformation-resistant erythrocytes, leads to platelet aggregation. In the face of the risk of thrombus formation, combating venous stasis and the factors that lead to it becomes crucial [13a-c] .
Diosmin and other flavonoids, such as chrysin, apigenin, luteolin and myricetin, extend the effect of noradrenaline on the vein wall. Noradrenaline, when released from neurovascular synapses, causes a contraction of vascular smooth muscle in the wall of the vein, which promotes venous return. Noradrenalin-releasing cells are also located in the walls of lymphatic vessels. These vessels are characterized by spontaneous contractile activity and respond to noradrenaline by increasing the frequency of contractions [13d]. The vasodilatory effects of flavonoids are related to their structure. The presence and position of hydroxyl groups on the B ring seems to be particularly important. For the vasodilatory effect, two orthopositioned hydroxyl groups on the B ring are essential. Moreover, the presence of a double bond between C2 and C3 of the benzopyran ring system increases the vasodilatory potency [15a,b] . Extending the duration of the effect of noradrenaline on vascular walls therefore stimulates not only venous return, but also the contractility of lymphatic vessels [13d,e]. All these are synergistic effects that counteract venous stasis: stimulating lymphatic vessel contractility enables previously developed edemas to be absorbed, while stimulating venous return reduces the excessive venous blood pressure that is responsible for the development of edemas [13e-g]. In addition, activated inflammatory mediators and endothelial cell activation may degrade extracellular matrix constituents by release of oxygen free radicals and matrix metalloproteinases (MMPs) activity [14a] . Venous hypertension induces morphological changes in valves, including fibrosis, with strong MMP-2 and MMP-9 activity in valves and during remodeling [14a,16a] .
The mechanical properties of the vessel wall depend to a great extent on extracellular matrix composition. Extensive changes of these mechanical properties have been demonstrated in the wall of varicose veins [14b] . Tissue remodeling is a complex process, which is controlled by numerous factors, including peptide growth factors. Increased content of transforming growth factor-β (TGF-β) and fibroblast growth factor (FGF) have been demonstrated in the wall of varicose veins. Furthermore, increased blood concentration of vascular endothelial growth factor (VEGF) was found in patients with varicose veins [14c,d] . VEGF levels decreased in patients with C4 venous insufficiency treated with a micronized purified flavonoid fraction (MPFF) (98 pg/mL to 58 pg/mL) [2d] . In light of these mechanisms for venous remodeling, future therapy schemes may have to be directed against the fundamental trigger mechanism, including leucocyte and endothelial cell activation [2e,16b] . Diosmin (Daflon ® ) administration reduced the edema, the valve annulus diameter, and fistula blood flow produced by the acute AVF in line with its ability to block elevation of microvascular permeability in inflammation [13h,17] . The MPFF also reduces granulocyte and macrophage infiltration in line with observations in Diosmin Natural Product Communications Vol. 8 (4) 2013 549 experimental acute ischemia and reperfusion or ischemia produced by venous hypertension [13i,16b] . Fluid shear stress on the endothelium, if accompanied by unsteady retrograde or even turbulent (with random fluctuation) stress, may be an inflammatory stimulus for the endothelial cells on a valve leaflet and may trigger cell apoptosis [18, 19] . In such conditions the degradation of the collagen matrix of the valve, and consequently mechanical softening and restructuring of the leaflets and the venous wall may occur [13d,e,18,19] .
Pathophysiology of venous insufficiency and the clinical aspect of the use of diosmin preparations: As mentioned above, phlebological pharmacotherapy plays an important role in treating venous stasis, edema and pain. Venous stasis not only initiates chronic ischemia of the lower limbs, but also exacerbates preexisting pathological conditions. This favors the development of edemas, initially by means of increased venous blood pressure, and later by the outflow of fluid from the vascular bed [13j]. The edema fluid is initially absorbed by the lymphatic system. However, the lymphatic drainage route is quickly overloaded, and the retention of fluid leads to the development of edema, which in turn leads to the development of further adverse effects [13j,k]. The "tension band" effect leads to reduced oxygenation of peripheral tissues and fosters the accumulation of toxic metabolites. These cause trophic skin disorders. Venous stasis is also a cause of hemodynamic disorders: increased hematocrit caused by a loss of protein and fluid from the vascular bed, increased blood viscosity, and increased resistance of morphotic blood elements to deformation. These hemodynamic disorders exacerbate venous stasis. This, combined with venous valve incompetence, creates a vicious circle. This is mainly driven by erythrocyte aggregation, as both blood viscosity and resistance to deformation are largely dependent on this phenomenon. Diosmin products are characterized by their effects on venous and lymphatic vessel systems and their protective effect on microcirculation vessels [13l,m] . This explains the efficacy of diosmin and other flavonoids in improving the function and protecting the structure of veins and lymphatic vessels in the treatment of chronic venous insufficiency [13j,k,m] . Volumetric measurements demonstrated significant efficacy of diosmin in reducing the severity of lower limb edema in another clinical trial. After 2 months of treatment, significant reduction in lower limb circumference was observed in diosmin-treated patients compared with the placebo group. Combination treatment with diosmin preparations and standard compression therapy was shown to accelerate the healing of venous ulceration of shanks and increase the ratio of completely healed ulcers [13j] . Diosmin was shown to reduce significantly lower limb edema as measured by several different methods (limb circumference, volumetry) [2f,13k,l] . The efficacy of diosmin compared with placebo in reducing the severity of lower limb edema was demonstrated in a clinical trial of 200 patients with functional or organic chronic venous insufficiency [13j,n] .
Administration of diosmin and other flavonoids led to an improvement in skin lesions associated with chronic venous insufficiency in 88% of patients after 2 months of treatment, compared with only 21% of patients in the placebo group A multicenter, placebo-controlled trial involving 107 patients with venous ulceration showed that after 2 months of treatment with a product containing diosmin at a dose of 2 tablets (one tablet = 450 mg micronized purified diosmin) per day, combined with simultaneous compression therapy and topical treatment, the ratio of healed ulcers was 32% as compared with 13% in the placebo group (p = 0.028) [13o] . Moreover, healing proceeded twice as fast in the diosmin group.
Conclusions: Diosmin has a wide range of biological activity, including an anti-inflammatory effect and an inhibition of prostaglandin synthesis [11c,12a] . Previous research on the phlebotropic effect of diosmin still does not give a clear answer whether the clinical effect is indeed conditioned by this action. Our review is an introduction to the choice of analytical methods for the determination of diosmin and its metabolites in peripheral blood of patients with chronic venous insufficiency. From the data reported in this short review, it can be seen that there are numerous techniques for the isolation and separation of diosmin from plant material, pharmaceutical formulations and biological fluids. Various analytical approaches exist for the detection of diosmin and the analytical methods should meet the following prerequisites: short time, be relatively inexpensive, highly accurate, and precise for a variety of applications. This review may be helpful in choosing a suitable method for diosmin isolation and analysis.
